OBJECTIVE To explore the molecular mechanism of Fas counterattack by observing the expression of Fas and FasL and apoptosis of the epithelium and infiltrative lymphocytes at different stages of intestinal epithelia malignant transformations and further to analyze the relationships among these processes. METHODS Using in-situ hybridization, the expression of Fas mRNA and FasL mRNA in paraffin-embedded tissues was determined. Apoptosis was assessed by the TUNEL method. The tumor specimens were as follows: 37 large intestinal adenocarcinomas, 26 malignant adenomas, 30 tubulo-villous adenomas, and 24 tubular adenomas. Six cases of non-tumor mucosas were used as controls. RESULTS With the progression of malignant transformation, Fas mRNA express...
CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apo...
Background and objective Tumor escape from the host immune system has been a major problem in immuno...
Background/Aims: Recent evidence suggests that alterations in regulation of apoptosis contribute to ...
AIM: To determine the role of Fas/Fas ligand (FasL) in the immune escape of colon cancer cells. METH...
The Fas and Fas ligand (FasL) play an Important role in maintaining immune privilege on malignant tu...
Esophageal and colorectal adenocarcinomas overexpress Fas ligand (FasL), which can protect them from...
Aims: To determine the extent of Fas expression in oesophageal squamous cell carcinomas (ESCCs) from...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The Fas system, comprising the Fas receptor (Fas/Apo-1/CD95) and its ligand, Fas ligand (FasL), is a...
AIM: To study the role of Fas ligand (FasL) and Caspase-3 expression in carcinogenesis and progressi...
Fas Ligand (FasL) expression by cancer cells may contribute to tumour immune escape via the Fas coun...
BACKGROUND /AIMS: Physiologic cell death occurs primarily through an evolutionary conserved form of ...
Subject headings colonic neoplasms/drug therapy; apoptosis; cisplatin/therapeutic use; mitomycins/ t...
i.f. 1.865 Aims: Fas ligand (FasL) expression by cancer cells may mediate tumour immune privilege. T...
Abstract: The study’s objective was to assess the expressions of Fas and FasL proteins in gastric ca...
CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apo...
Background and objective Tumor escape from the host immune system has been a major problem in immuno...
Background/Aims: Recent evidence suggests that alterations in regulation of apoptosis contribute to ...
AIM: To determine the role of Fas/Fas ligand (FasL) in the immune escape of colon cancer cells. METH...
The Fas and Fas ligand (FasL) play an Important role in maintaining immune privilege on malignant tu...
Esophageal and colorectal adenocarcinomas overexpress Fas ligand (FasL), which can protect them from...
Aims: To determine the extent of Fas expression in oesophageal squamous cell carcinomas (ESCCs) from...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The Fas system, comprising the Fas receptor (Fas/Apo-1/CD95) and its ligand, Fas ligand (FasL), is a...
AIM: To study the role of Fas ligand (FasL) and Caspase-3 expression in carcinogenesis and progressi...
Fas Ligand (FasL) expression by cancer cells may contribute to tumour immune escape via the Fas coun...
BACKGROUND /AIMS: Physiologic cell death occurs primarily through an evolutionary conserved form of ...
Subject headings colonic neoplasms/drug therapy; apoptosis; cisplatin/therapeutic use; mitomycins/ t...
i.f. 1.865 Aims: Fas ligand (FasL) expression by cancer cells may mediate tumour immune privilege. T...
Abstract: The study’s objective was to assess the expressions of Fas and FasL proteins in gastric ca...
CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apo...
Background and objective Tumor escape from the host immune system has been a major problem in immuno...
Background/Aims: Recent evidence suggests that alterations in regulation of apoptosis contribute to ...